INFANT HEARING PROGRAM: AccuScreen and Program - Review. Winter 2013. INFANT HEARING PROGRAM OVERVIEW. Follow local IHP or hospital protocol for infection control procedures. Screening occurs before discharge and will include a risk assessment. Infant can be tested in crib or parent’s arms.
AccuScreen and Program - Review
M. Hyde, IHP Conference 2007
Results will appear as Probe OK or Probe failed with possible errors.
Family history – Hearing loss must have occurred in the baby’s parent or sibling under the age of 10 and been a clear case of hearing loss that involved:
Viruses and Infections:
CMV, CCMV (congenital) cytomegalovirus
Proven TORCHES infections (Toxoplasmosis (from cat feces or meat), Rubella (German Measles), Herpes, Syphilis
Proven Menigitis (Viral, Bacterial or Fungal)
Congenital HIV, Measles or mumps infection
Severe neonatal sepsis
HBR - Hyperbilirubinemia >= 400 µmol/L or exchange (jaundice)
Neonatal cancer treatment with cisplatin
Down (Trisomy 21), Stickler, CHARGE, Pendred, Enlarged Vestibular Aqueduct (EVA), Waardenburg, Usher, Branchio-Oto-Renal (BOR), Treacher Collins, OsteogenesisImperfecta (OI), Neurofibromatosis II (NF2), Alport, Crouzon, Hunter.
Other high risk indicators
As specified by baby’s physician
Please contact your Infant Hearing Program Regional Trainer
or Infant Hearing Program Coordinator